Advertisement
Screener

STAAR Surgical Co (STAA) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.8 / 5 stars · 68/120 Roast Me

STAAR Surgical Co Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-07-03 was 68.00K shares, a 6700.00% increase year-over-year.
  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-04-03 was 20.00K shares, a 61.54% decline year-over-year.
  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-01-02 was 11.00K shares, a 120.00% increase year-over-year.
  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-26 was 157.00K shares, a 49.52% increase year-over-year.
  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 221.00K shares, a 29.84% decline from fiscal 2024.
  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 315.00K shares, a 39.19% decline from fiscal 2023.
  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 518.00K shares, a 21.31% increase from fiscal 2022.
  • STAAR Surgical Co share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 427.00K shares, a 64.59% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2026-07-0368.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
256.00K shares
derived: sum of 4 quarters · filed 2026-08-12
2026-04-0320.00K shares
10-Q · filed 2026-05-13
189.00K shares
derived: sum of 4 quarters · filed 2026-05-13
2026-01-0211.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03
221.00K shares
10-K · filed 2026-03-03
2025-09-26157.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
215.00K shares
derived: sum of 4 quarters · filed 2025-11-05
2025-06-271.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
163.00K shares
derived: sum of 4 quarters · filed 2025-08-06
2025-03-2852.00K shares
10-Q · filed 2025-05-07
180.00K shares
derived: sum of 4 quarters · filed 2025-05-07
2024-12-275.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21
315.00K shares
10-K · filed 2025-02-21
2024-09-27105.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
328.00K shares
derived: sum of 4 quarters · filed 2024-10-30
2024-06-2818.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
528.00K shares
derived: sum of 4 quarters · filed 2024-08-07
2024-03-29187.00K shares
10-Q · filed 2024-05-07
665.00K shares
derived: sum of 4 quarters · filed 2024-05-07
2023-12-2918.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
518.00K shares
10-K · filed 2024-02-27
2023-09-29305.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
510.00K shares
derived: sum of 4 quarters · filed 2023-11-06
2023-06-30155.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
371.00K shares
derived: sum of 4 quarters · filed 2023-08-02
2023-03-3140.00K shares
10-Q · filed 2023-05-03
418.00K shares
derived: sum of 4 quarters · filed 2023-05-03
2022-12-3010.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
427.00K shares
10-K · filed 2023-02-23
2022-09-30166.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
534.00K shares
derived: sum of 4 quarters · filed 2022-11-02
2022-07-01202.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
551.00K shares
derived: sum of 4 quarters · filed 2022-08-10
2022-04-0149.00K shares
10-Q · filed 2022-05-04
879.00K shares
derived: sum of 4 quarters · filed 2022-05-04
2021-12-31117.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
1.21M shares
10-K · filed 2022-02-23
2021-10-01183.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
1.45M shares
derived: sum of 4 quarters · filed 2021-11-03
2021-07-02530.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
1.54M shares
derived: sum of 4 quarters · filed 2021-08-04
2021-04-02376.00K shares
10-Q · filed 2021-05-05
1.69M shares
derived: sum of 4 quarters · filed 2021-05-05
2021-01-01361.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
1.51M shares
10-K · filed 2021-02-24
2020-10-02270.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
1.34M shares
derived: sum of 4 quarters · filed 2020-11-04
2020-07-03680.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
1.14M shares
derived: sum of 4 quarters · filed 2020-08-05
2020-04-03196.00K shares
10-Q · filed 2020-05-06
510.00K shares
derived: sum of 4 quarters · filed 2020-05-06
2020-01-03198.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
388.00K shares
10-K · filed 2020-02-26
2019-09-2764.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
2019-06-2852.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
2019-03-2974.00K shares
10-Q · filed 2019-05-01
2018-12-28596.00K shares
10-K · filed 2019-02-21
2017-12-29557.00K shares
10-K · filed 2018-02-28
2017-06-30172.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
564.00K shares
derived: sum of 4 quarters · filed 2017-08-02
2017-03-31116.00K shares
10-Q · filed 2017-05-03
656.00K shares
derived: sum of 4 quarters · filed 2017-05-03
2016-12-30117.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02
541.00K shares
10-K · filed 2017-03-02
2016-09-30159.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
428.00K shares
derived: sum of 4 quarters · filed 2016-11-03
2016-07-01264.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
317.00K shares
derived: sum of 4 quarters · filed 2016-08-03
2016-04-011.00K shares
10-Q · filed 2016-05-11
373.00K shares
derived: sum of 4 quarters · filed 2016-05-11
2016-01-014.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
476.00K shares
10-K · filed 2016-03-11
2015-10-0248.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
2015-07-03320.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
2015-04-03104.00K shares
10-Q · filed 2015-05-12
2015-01-02584.00K shares
10-K · filed 2015-03-13
2014-01-03645.00K shares
10-K · filed 2014-03-12
2013-03-299.00K shares
10-Q · filed 2013-05-03
2012-12-28324.00K shares
10-K · filed 2013-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
National Vision Holdings, Inc. (EYE)United States$1.297B
RxSight, Inc. (RXST)United States$0.197B
Innovative Eyewear Inc (LUCY)United States$0.008B
Warby Parker Inc. (WRBY)United States$2.970B
Bausch & Lomb Corp (BLCO)Canada$6.008B-34.58
COOPER COMPANIES, INC. (COO)United States$10.533B24.09